Market Overview:
The global prosthetic heart valve/ artificial heart valve market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in prosthetic heart valves, and rising geriatric population. The global prosthetic heart valve/ artificial heart valve market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into transcatheter heart valves (TAHVs), tissue Heart valves (THVs), and mechanical Heart valves (MV). TAHVs are further sub-segmented into tilting disc TAHVs and balloon expandable TAHVs. THVs are further sub-segmented into bioprosthetic THVs and mechanical THVSs. MV are further sub-segmented into stented MV and unstented MV. On the basis of application, the market is segmented into rheumatic Heart disease (RHD), congenital Heart disease (CHD), Marfan syndrome, other applications such as aortic aneurysm repair surgery etc., and undetermined applications.
Product Definition:
A prosthetic heart valve is a mechanical device that replaces a diseased or malfunctioning heart valve. It is implanted during surgery to repair or replace a natural heart valve.
Transcatheter Heart Valve:
Transcatheter heart valve is a kind of artificial heart valve which is implanted in the patient’s body. It's major function is to help the patients suffering from cardiovascular diseases to live longer and healthier life. The other important factor that influences market growth includes rising prevalence of Cardiovascular Diseases (CVD) globally, increasing demand for minimally invasive surgeries, and growing geriatric population base across the globe.
Tissue Heart Valve:
The tissue heart valve is a small rubber device that opens and closes to allow blood flow through the heart. It is placed in the patient’s heart by means of catheterization. The valve can be taken out when it gets damaged or infected and then replaced with another one.
Application Insights:
Rheumatic heart diseases held the largest market share in 2017 owing to the increasing prevalence of rheumatoid arthritis, systemic lupus erythematosus, and other rheumatic disorders. Moreover, this segment is expected to grow at a lucrative rate during the forecast period due to technological advancements in valve implantsation such as 3D printed prosthetic valves.
Congenital heart diseases are also anticipated to witness significant growth over the forecast period due to rising awareness about CVDs among individuals suffering from birth defects & infant mortality rates are increasing day by day which further increases awareness about CVDs among adults. Marfan syndrome is also one of the most common congenital heart disease which affects approximately 70,000 individuals world wide and is more prevalent amongst women than men.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to various factors such as favorable reimbursement policies, rising healthcare expenditure, and increasing awareness about available products. Moreover, the presence of key players in this region is expected to boost growth during the forecast period. Europe accounted for a significant share of revenue due to growing geriatric population prone to cardiac diseases and high incidence of congenital heart diseases (CHDs). In addition, technological advancements coupled with increased funding by government bodies are some other factors driving growth in this region. Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to huge unmet needs regarding CHDs & valvular disorders coupled with rapidly improving healthcare infrastructure & facilities especially in India and China.
Major companies include Abbott; Fresenius Kabi; Medtronic; St Jude Medical Inc.
Growth Factors:
- Increasing incidence of heart valve diseases: The increasing incidence of heart valve diseases is one of the key growth drivers for the prosthetic heart valve/artificial heart valve market. According to a study by the American Heart Association, around 5.8 million Americans are affected by some form of valvular disease, and this number is expected to rise in the coming years due to factors such as an aging population and rising rates of obesity and diabetes. This will create significant demand for prosthetic heart valves/artificial heart valves in the coming years.
- Technological advancements: The technological advancements in prosthetic heart valves/artificial heart valves are another key growth driver for this market. With continuous innovations taking place, these devices are becoming increasingly sophisticated and reliable, thus resulting in increased adoption rates worldwide.
- Growing awareness about benefits of prosthetic hearts valves/artificial hearts valves: There is growing awareness about the benefits of using prosthetic hearts valves/artificial hearts valves among patients suffering from various types of cardiac disorders across the globe. This is helping to drive demand for these devices significantly over time..
Scope Of The Report
Report Attributes
Report Details
Report Title
Prosthetic Heart Valve/ Artificial Heart Valve Market Research Report
By Type
Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve
By Application
Rheumatic Heart Disease, Congenital Heart Disease, Marfan Syndrome, Other
By Companies
Edwards Lifesciences Corporation, Medtronic Plc, St. Jude Medical Inc. (Abbott Laboratories Company), Boston Scientific Corporation, Livanova Plc, Symetis, Jenavalve Technology Inc., Cryolife Inc., Ttk Healthcare Limited, Colibri Heart Valve, Lepu Medical Technology, Braile Biomédica, Micro Interventional Devices, Autotissue Berlin Gmbh, Comed B.V., Meril Life Sciences, Labcor Laboratório, HLT Inc. (A Bracco Group Company), Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Livanova Plc, St. Jude Medical, Inc. (An Abbott Laboratories Company), Symetis Sa, Jenavalve Technology, Inc., Cryolife, Inc., TTK Healthcare Limited (A Ttk Group Company), Colibri Heart Valve, Llc, Lepu Medical Technology Co., Ltd., Braile Biomédica
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Prosthetic Heart Valve/ Artificial Heart Valve Market Report Segments:
The global Prosthetic Heart Valve/ Artificial Heart Valve market is segmented on the basis of:
Types
Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Rheumatic Heart Disease, Congenital Heart Disease, Marfan Syndrome, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Edwards Lifesciences Corporation
- Medtronic Plc
- St. Jude Medical Inc. (Abbott Laboratories Company)
- Boston Scientific Corporation
- Livanova Plc
- Symetis
- Jenavalve Technology Inc.
- Cryolife Inc.
- Ttk Healthcare Limited
- Colibri Heart Valve
- Lepu Medical Technology
- Braile Biomédica
- Micro Interventional Devices
- Autotissue Berlin Gmbh
- Comed B.V.
- Meril Life Sciences
- Labcor Laboratório
- HLT Inc. (A Bracco Group Company)
- Medtronic
- Edwards Lifesciences Corporation
- Boston Scientific Corporation
- Livanova Plc
- St. Jude Medical, Inc. (An Abbott Laboratories Company)
- Symetis Sa
- Jenavalve Technology, Inc.
- Cryolife, Inc.
- TTK Healthcare Limited (A Ttk Group Company)
- Colibri Heart Valve, Llc
- Lepu Medical Technology Co., Ltd.
- Braile Biomédica
Highlights of The Prosthetic Heart Valve/ Artificial Heart Valve Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transcatheter Heart Valve
- Tissue Heart Valve
- Mechanical Heart Valve
- By Application:
- Rheumatic Heart Disease
- Congenital Heart Disease
- Marfan Syndrome
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prosthetic Heart Valve/ Artificial Heart Valve Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A prosthetic heart valve is a medical device that replaces a natural heart valve. Artificial hearts are used to treat patients with end-stage heart failure.
Some of the key players operating in the prosthetic heart valve/ artificial heart valve market are Edwards Lifesciences Corporation, Medtronic Plc, St. Jude Medical Inc. (Abbott Laboratories Company), Boston Scientific Corporation, Livanova Plc, Symetis, Jenavalve Technology Inc., Cryolife Inc., Ttk Healthcare Limited, Colibri Heart Valve, Lepu Medical Technology, Braile BiomƒÂ©dica, Micro Interventional Devices, Autotissue Berlin Gmbh, Comed B.V., Meril Life Sciences, Labcor LaboratƒÂ³rio, HLT Inc. (A Bracco Group Company), Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Livanova Plc, St. Jude Medical, Inc. (An Abbott Laboratories Company), Symetis Sa, Jenavalve Technology, Inc., Cryolife, Inc., TTK Healthcare Limited (A Ttk Group Company), Colibri Heart Valve, Llc, Lepu Medical Technology Co., Ltd., Braile BiomƒÂ©dica.
The prosthetic heart valve/ artificial heart valve market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Prosthetic Heart Valve/ Artificial Heart Valve Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Prosthetic Heart Valve/ Artificial Heart Valve Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Prosthetic Heart Valve/ Artificial Heart Valve Market - Supply Chain
4.5. Global Prosthetic Heart Valve/ Artificial Heart Valve Market Forecast
4.5.1. Prosthetic Heart Valve/ Artificial Heart Valve Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Prosthetic Heart Valve/ Artificial Heart Valve Market Size (000 Units) and Y-o-Y Growth
4.5.3. Prosthetic Heart Valve/ Artificial Heart Valve Market Absolute $ Opportunity
5. Global Prosthetic Heart Valve/ Artificial Heart Valve Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Type
5.3.1. Transcatheter Heart Valve
5.3.2. Tissue Heart Valve
5.3.3. Mechanical Heart Valve
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Prosthetic Heart Valve/ Artificial Heart Valve Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Application
6.3.1. Rheumatic Heart Disease
6.3.2. Congenital Heart Disease
6.3.3. Marfan Syndrome
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Prosthetic Heart Valve/ Artificial Heart Valve Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Prosthetic Heart Valve/ Artificial Heart Valve Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Prosthetic Heart Valve/ Artificial Heart Valve Demand Share Forecast, 2019-2026
9. North America Prosthetic Heart Valve/ Artificial Heart Valve Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Application
9.4.1. Rheumatic Heart Disease
9.4.2. Congenital Heart Disease
9.4.3. Marfan Syndrome
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Type
9.7.1. Transcatheter Heart Valve
9.7.2. Tissue Heart Valve
9.7.3. Mechanical Heart Valve
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Prosthetic Heart Valve/ Artificial Heart Valve Demand Share Forecast, 2019-2026
10. Latin America Prosthetic Heart Valve/ Artificial Heart Valve Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Application
10.4.1. Rheumatic Heart Disease
10.4.2. Congenital Heart Disease
10.4.3. Marfan Syndrome
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Type
10.7.1. Transcatheter Heart Valve
10.7.2. Tissue Heart Valve
10.7.3. Mechanical Heart Valve
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Prosthetic Heart Valve/ Artificial Heart Valve Demand Share Forecast, 2019-2026
11. Europe Prosthetic Heart Valve/ Artificial Heart Valve Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Application
11.4.1. Rheumatic Heart Disease
11.4.2. Congenital Heart Disease
11.4.3. Marfan Syndrome
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Type
11.7.1. ranscatheter Heart Valve
11.7.2. Tissue Heart Valve
11.7.3. Mechanical Heart Valve
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Prosthetic Heart Valve/ Artificial Heart Valve Demand Share, 2019-2026
12. Asia Pacific Prosthetic Heart Valve/ Artificial Heart Valve Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Application
12.4.1. Rheumatic Heart Disease
12.4.2. Congenital Heart Disease
12.4.3. Marfan Syndrome
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Type
12.7.1. Transcatheter Heart Valve
12.7.2. Tissue Heart Valve
12.7.3. Mechanical Heart Valve
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Prosthetic Heart Valve/ Artificial Heart Valve Demand Share, 2019-2026
13. Middle East & Africa Prosthetic Heart Valve/ Artificial Heart Valve Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Application
13.4.1. Rheumatic Heart Disease
13.4.2. Congenital Heart Disease
13.4.3. Marfan Syndrome
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Prosthetic Heart Valve/ Artificial Heart Valve Market Size and Volume Forecast by Type
13.7.1. Transcatheter Heart Valve
13.7.2. Tissue Heart Valve
13.7.3. Mechanical Heart Valve
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Prosthetic Heart Valve/ Artificial Heart Valve Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Prosthetic Heart Valve/ Artificial Heart Valve Market: Market Share Analysis
14.2. Prosthetic Heart Valve/ Artificial Heart Valve Distributors and Customers
14.3. Prosthetic Heart Valve/ Artificial Heart Valve Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Edwards Lifesciences Corporation
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic Plc
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. St. Jude Medical Inc. (Abbott Laboratories Company)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boston Scientific Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Livanova Plc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Symetis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Jenavalve Technology Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cryolife Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Ttk Healthcare Limited
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Colibri Heart Valve
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Lepu Medical Technology
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Braile Biomédica
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Micro Interventional Devices
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Autotissue Berlin Gmbh
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Comed B.V.
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Meril Life Sciences
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Labcor Laboratório
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. HLT Inc. (A Bracco Group Company)
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Medtronic
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Edwards Lifesciences Corporation
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
